Ikarian Capital, LLC Macrogenics Inc Transaction History

Ikarian Capital, LLC

$573 Million
Q3 2024

A detailed history of Ikarian Capital, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Ikarian Capital, LLC holds 80,079 shares of MGNX stock, worth $254,651. This represents 0.05% of its overall portfolio holdings.

Number of Shares

80,079

Previous 200,079 59.98%

Holding current value

$254,651

Previous $850,000 69.06%

% of portfolio

0.05%

Previous 0.34%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $360,000 - $666,000	-120,000 Reduced 59.98%	80,079 $263,000
Q2 2024 Aug 14, 2024	SELL	$3.31 - $18.51 $390,871 - $2.19 Million	-118,088 Reduced 37.12%	200,079 $850,000
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $3.11 Million - $6.83 Million	318,167 New	318,167 $4.68 Million
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $1.21 Million - $1.81 Million	250,000 New	250,000 $1.79 Million
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $369,267 - $1.64 Million	-164,119 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.12 - $16.9 $65,544 - $136,416	8,072 Added 5.17%	164,119 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $515,977 - $709,590	-32,431 Reduced 17.21%	156,047 $2.51 Million
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $5.35 Million - $7.78 Million	-271,124 Reduced 58.99%	188,478 $3.95 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $837,364 - $1.46 Million	-40,867 Reduced 8.17%	459,602 $12.3 Million
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $9.5 Million - $16.6 Million	500,469 New	500,469 $15.9 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $1.87 Million - $10.5 Million	-360,030 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $1.5 Million - $4.24 Million	350,000 Added 3489.53%	360,030 $2.1 Million
Q4 2019 Jan 31, 2020	BUY	$7.95 - $12.27 $79,738 - $123,068	10,030 New	10,030 $109,000

Others Institutions Holding MGNX

# of Institutions

131

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $195M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Account

Ikarian Capital, LLC Macrogenics Inc Transaction History